GNI Group Ltd. 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-30 7:28 pm Unchanged | 2023-10-27 | 13D | CATALYST BIOSCIENCES INC N CBIO | GNI Group Ltd. | 62,665 16.500% | 0 (Unchanged) | Filing |
| 2023-01-04 6:13 pm Purchase | 2022-12-26 | 13D | CATALYST BIOSCIENCES INC N CBIO | GNI Group Ltd. | 62,665 16.600% | 62,665 (New Position) | Filing |